BRO vs DNLI · P/E 30, rev $4.80B vs $2.11B cap
Brown & Brown Inc (BRO) versus Denali Therapeutics Inc (DNLI) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported DNLI revenue for 2024-12-31 was $0. Net income was -$422.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. DNLI currently screens at market cap $2.11B.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. DNLI currently screens at market cap $2.11B.
Not investment advice. Open the BRO and DNLI stock pages for the full models.
Not investment advice.